JP2003511477A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003511477A5 JP2003511477A5 JP2001531090A JP2001531090A JP2003511477A5 JP 2003511477 A5 JP2003511477 A5 JP 2003511477A5 JP 2001531090 A JP2001531090 A JP 2001531090A JP 2001531090 A JP2001531090 A JP 2001531090A JP 2003511477 A5 JP2003511477 A5 JP 2003511477A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/418,594 US6214874B1 (en) | 1999-10-15 | 1999-10-15 | Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N |
| US09/418,594 | 1999-10-15 | ||
| PCT/US2000/028612 WO2001028494A2 (en) | 1999-10-15 | 2000-10-16 | Nordihydroguaiaretic derivatives for use in treatment of tumors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007263845A Division JP2008019278A (ja) | 1999-10-15 | 2007-10-09 | 腫瘍の処置における使用のためのノルジヒドログアイアレチン酸誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003511477A JP2003511477A (ja) | 2003-03-25 |
| JP2003511477A5 true JP2003511477A5 (enExample) | 2005-12-22 |
| JP4062664B2 JP4062664B2 (ja) | 2008-03-19 |
Family
ID=23658774
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001531090A Expired - Lifetime JP4062664B2 (ja) | 1999-10-15 | 2000-10-16 | 腫瘍の処置における使用のためのノルジヒドログアイアレチン酸誘導体 |
| JP2007263845A Pending JP2008019278A (ja) | 1999-10-15 | 2007-10-09 | 腫瘍の処置における使用のためのノルジヒドログアイアレチン酸誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007263845A Pending JP2008019278A (ja) | 1999-10-15 | 2007-10-09 | 腫瘍の処置における使用のためのノルジヒドログアイアレチン酸誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US6214874B1 (enExample) |
| EP (1) | EP1231914B1 (enExample) |
| JP (2) | JP4062664B2 (enExample) |
| CN (1) | CN1309381C (enExample) |
| AT (1) | ATE350030T1 (enExample) |
| AU (1) | AU783015C (enExample) |
| CA (1) | CA2387873C (enExample) |
| DE (1) | DE60032795T2 (enExample) |
| SG (1) | SG144712A1 (enExample) |
| WO (1) | WO2001028494A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6365787B1 (en) * | 1994-09-30 | 2002-04-02 | The Johns Hopkins University | Compounds for the suppression of HIV TAT transactivation |
| US6608108B2 (en) * | 1999-10-15 | 2003-08-19 | Johns Hopkins University | Method for treatment of tumors using nordihydroguaiaretic acid derivatives |
| US6214874B1 (en) * | 1999-10-15 | 2001-04-10 | John Hopkins University | Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N |
| US20060073530A1 (en) * | 2001-08-15 | 2006-04-06 | Olaf Schneewind | Methods and compositions involving sortase B |
| US7728036B2 (en) * | 2003-05-20 | 2010-06-01 | Erimos Pharmaceuticals, Llc | Methods for delivery of catecholic butanes for treatment of tumors |
| US20060141029A1 (en) * | 2003-05-20 | 2006-06-29 | Erimos Pharmaceuticals Llc | Methods and compositions for delivery of catecholic butanes for treatment of diseases |
| AU2004249123A1 (en) * | 2003-05-20 | 2004-12-29 | Erimos Pharmaceuticals Llc | Methods and compositions for delivery of catecholic butanes for treatment of obesity |
| DE602004019217D1 (en) * | 2003-08-07 | 2009-03-12 | Huntsman Adv Mat Switzerland | Photovernetzbare polyurethane |
| CN100440843C (zh) * | 2004-05-12 | 2008-12-03 | 华为技术有限公司 | 一种环网及其业务实现方法 |
| EP1748767B1 (en) * | 2004-05-28 | 2011-12-28 | Unigen, Inc. | 1-(3-methyl-2,4-dimethoxyphenyl)-3-(2',4'-dihydroxyphenyl)-propane as a potent tyrosinase inhibitor |
| US8440648B2 (en) * | 2004-07-20 | 2013-05-14 | Erimos Pharmaceuticals Llc | Methods and compositions for treatment of intraepithelial neoplasia |
| WO2006014669A2 (en) * | 2004-07-20 | 2006-02-09 | Erimos Pharmaceuticals Llc | Methods and compositions for treatment of intraepithelial neoplasia |
| MX2007004025A (es) * | 2004-10-06 | 2007-06-11 | Univ Johns Hopkins | Uso de derivados del acido nordihidroguaiaretico en el tratamiento de cancer e infecciones microbial y viral resistente a farmacos._. |
| JP5069130B2 (ja) * | 2005-01-27 | 2012-11-07 | エリモス・ファーマスーティカルズ・エルエルシー | Ｎｄｇａ化合物を包含するカテコールブタンの送達のための経口用製剤 |
| EP1996174A2 (en) * | 2006-02-23 | 2008-12-03 | Erimos Pharmaceuticals LLC | Methods of treating influenza viral infections |
| US9067875B2 (en) | 2006-10-02 | 2015-06-30 | Erimos Pharmaceuticals Llc | Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| ES2476249T3 (es) * | 2006-10-02 | 2014-07-14 | Erimos Pharmaceuticals Llc | Derivados del NDGA tetrasustituidos por medio de enlaces éter y enlaces carbamatos y sus síntesis y usos farmacéuticos |
| WO2008088806A1 (en) * | 2007-01-16 | 2008-07-24 | Johns Hopkins University | Combinational paradigm combating hiv, hiv/hsv, or hiv/hpv infections in humans using small molecular weight compounds from plants |
| ES2588235T3 (es) * | 2007-05-11 | 2016-10-31 | Convatec Technologies Inc. | Dispositivo de ostomía |
| AU2009274158C1 (en) | 2008-07-21 | 2019-09-05 | Unigen, Inc. | Series of skin-whitening (lightening) compounds |
| WO2010011117A2 (ko) * | 2008-07-25 | 2010-01-28 | 국립암센터 | Ｎｄｇａ를 포함하는 트란스글루타미나제 억제용 조성물 |
| US20100093872A1 (en) * | 2008-10-15 | 2010-04-15 | Erimos Pharmaceuticals Llc | Stable aqueous formulations of water insoluble or poorly soluble drugs |
| MX2011004824A (es) * | 2008-11-07 | 2012-01-12 | Triact Therapeutics Inc | Uso de derivados de butano catecólico en terapia contra el cáncer. |
| US8586799B2 (en) | 2011-03-24 | 2013-11-19 | Unigen, Inc. | Compounds and methods for preparation of diarylpropanes |
| WO2012166778A2 (en) * | 2011-05-31 | 2012-12-06 | The Johns Hopkins University | Conjugates of nitroimidazoles and their use as chemotherapeutic agents |
| SG11201500397XA (en) * | 2012-07-18 | 2015-03-30 | Univ Johns Hopkins | Methods for inhibition of bnip3 and prevention and treatment of ischemia reperfusion injury by tetra-o-methyl nordihydroguaiaretic acid |
| US9834575B2 (en) | 2013-02-26 | 2017-12-05 | Triact Therapeutics, Inc. | Cancer therapy |
| CA2923667A1 (en) * | 2013-09-09 | 2015-03-12 | Triact Therapeutics, Inc. | Cancer therapy |
| MX391317B (es) | 2017-02-17 | 2025-03-21 | Promotora Tecnica Ind S A De C V | Composicion mejorada a base de acido norhidroguayaretico. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5008294A (en) * | 1985-02-11 | 1991-04-16 | Chemex Pharmaceuticals, Inc. | Methods of treating tumors with compositions of catecholic butanes |
| US5276060A (en) * | 1979-06-19 | 1994-01-04 | Block/Chemex, G.P. | Methods of treating tumors with compositions of catecholic butanes |
| DE3009542A1 (de) * | 1980-03-13 | 1981-09-24 | Henkel KGaA, 4000 Düsseldorf | Desodorierende kosmetische zusammensetzungen |
| US4774229A (en) * | 1982-04-05 | 1988-09-27 | Chemex Pharmaceuticals, Inc. | Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor |
| US4880637A (en) * | 1985-02-11 | 1989-11-14 | Chemex Pharmaceuticals, Inc. | Compositions of catecholic butanes with zinc |
| US5559149A (en) * | 1990-01-29 | 1996-09-24 | Johnson & Johnson Consumer Products, Inc. | Skin care compositions containing retinoids |
| US5646186A (en) * | 1994-05-17 | 1997-07-08 | Johnson & Johnson Consumer Products, Inc. | Retinoid composition |
| US6071949A (en) * | 1995-03-14 | 2000-06-06 | The United States Of America As Represented By The Department Of Health And Human Services | Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents |
| US5837252A (en) | 1996-07-01 | 1998-11-17 | Larreacorp, Ltd. | Nontoxic extract of Larrea tridentata and method of making same |
| US5827898A (en) * | 1996-10-07 | 1998-10-27 | Shaman Pharmaceuticals, Inc. | Use of bisphenolic compounds to treat type II diabetes |
| US6214874B1 (en) * | 1999-10-15 | 2001-04-10 | John Hopkins University | Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N |
-
1999
- 1999-10-15 US US09/418,594 patent/US6214874B1/en not_active Expired - Lifetime
-
2000
- 2000-10-16 JP JP2001531090A patent/JP4062664B2/ja not_active Expired - Lifetime
- 2000-10-16 CA CA002387873A patent/CA2387873C/en not_active Expired - Lifetime
- 2000-10-16 AU AU12075/01A patent/AU783015C/en not_active Ceased
- 2000-10-16 CN CNB008160228A patent/CN1309381C/zh not_active Expired - Lifetime
- 2000-10-16 AT AT00973576T patent/ATE350030T1/de not_active IP Right Cessation
- 2000-10-16 DE DE60032795T patent/DE60032795T2/de not_active Expired - Lifetime
- 2000-10-16 SG SG200402053-3A patent/SG144712A1/en unknown
- 2000-10-16 US US09/690,063 patent/US6417234B1/en not_active Expired - Lifetime
- 2000-10-16 EP EP00973576A patent/EP1231914B1/en not_active Expired - Lifetime
- 2000-10-16 WO PCT/US2000/028612 patent/WO2001028494A2/en not_active Ceased
-
2002
- 2002-04-11 US US10/119,899 patent/US6958411B2/en not_active Expired - Lifetime
-
2005
- 2005-05-04 US US11/121,093 patent/US20050267208A1/en not_active Abandoned
-
2007
- 2007-10-09 JP JP2007263845A patent/JP2008019278A/ja active Pending